LN-503134
Palbociclib-012 , 0.95 , 2206135-30-8
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 918.6±75.0 °C(Predicted) |
| Density | 1.302±0.06 g/cm3(Predicted) |
| pka | 6.28±0.10(Predicted) |
| InChIKey | ZXAOMPKUBCILTQ-UHFFFAOYSA-N |
| SMILES | O=C1C(=C(C2=CN=C(N=C2N1C1CCCC1)NC1N=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=CC=1)C)NC1N=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=CC=1 |
Description and Uses
di-tert-Butyl 4,4''-(6,6''-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(azanediyl))bis(pyridine-6,3-diyl))bis(piperazine-1-carboxylate) is an impurity of Palbociclib (P139900) an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.





![6-bromo-2-chloro-8-cyclopentyl-5-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one](https://img.chemicalbook.com/CAS/GIF/1016636-76-2.gif)
